TEM241101C51000
- 0.25
- 0.000.00%
Tempus AI Newsroom
Tempus to Report Third Quarter 2024 Financial Results on November 7
Cathie Wood's ARK Offloads Robinhood Stock, Buys Tempus AI
Avacta Collaborates With Tempus AI for Cancer Drug Development
Cathie Wood's ARK ETF Focuses on Tempus AI and AMD Stock
Loop Capital Maintains Tempus AI(TEM.US) With Buy Rating, Raises Target Price to $57
Tempus AI Is Maintained at Buy by Loop Capital
Loop Capital Maintains Buy on Tempus AI, Raises Price Target to $57
Tempus AI, Inc (TEM): A Bull Case Theory
Tempus AI Cut to Neutral From Buy by B of A Securities
Tempus AI Analyst Ratings
BofA Securities Downgrades Tempus AI(TEM.US) to Hold Rating, Raises Target Price to $60
Unusual Options Activity: WYNN, UBS and Others Attract Market Bets, WYNN V/OI Ratio Reaches 222.2
EST Sep 26th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Tempus With Takeda Announces Expansion Of Collaboration To Leverage Multimodal Real-World Datasets And Biological Model Systems In Oncology Research And Development
Express News | Tempus Announces Expansion of Collaboration With Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024
Tempus Launches Beta Version of Olivia, Its AI-enabled Personal Health Concierge App for Patients
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
Cathie Wood's ARK ETF Adjusts Portfolio, Buys Tempus AI Stock and Sells Trade Desk
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Tempus Announces Real World Data Collaboration With BioNTech